Investigational New Drug CDMO Market Size, Share & Trends Report

Investigational New Drug CDMO Market Size, Share & Trends Analysis Report By Product (Small Molecule, Large Molecule), By Service (Contract Development, Contract Manufacturing), By End User, And Segment Forecasts, 2021 - 2028

  • Published Date: Sep, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68039-537-3
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 100

Market Segmentation

  • IND CDMO Product Outlook (Revenue, USD Million, 2016 - 2028)
    • Small Molecule
    • Large Molecule
  • IND CDMO Service Outlook (Revenue, USD Million, 2016 - 2028)
    • Contract Development
      • Small Molecule
        • Bioanalysis and DMPK studies
        • Toxicology Testing
        • Pathology and safety pharmacology studies
        • Drug substance synthetic route development
        • Drug substance process development
        • Form selection crystallization process development
        • Scale-up of drug substance
        • Preformulation
        • Preclinical formulation selection
        • First in Man Formulation/Process Development
        • Analytical method development/validation
        • Release testing of drug substance and drug product
        • Work up Purification Steps
        • Telescoping & Process Refining
        • Initial Optimization
        • Formal stability of drug substance and drug product
      • Large Molecule
        • Cell Line development
        • Process Development
          • Upstream
            • Microbial
            • Mammalian
            • Others
          • Downstream
            • MABs
            • Recombinant proteins
            • Others
    • Contract Manufacturing
      • Small Molecule
        • Oral Solids
        • Liquid and Semi-solids
        • Injectables
        • Others
      • Large Molecule
        • MABs
        • Recombinant proteins
        • Others
  • IND CDMO End-user Outlook (Revenue, USD Million, 2016 - 2028)
    • Pharmaceutical Companies
    • Biotech Companies
    • Others (Government, Research Institutes, Academic Institutes, Etc.)
  • IND CDMO Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
      • North America IND CDMO Market, By Product
        • Small Molecule
        • Large Molecule
      • North America IND CDMO Market, By Service
        • Contract Development
          • Small Molecule
            • Bioanalysis and DMPK studies
            • Toxicology Testing
            • Pathology and safety pharmacology studies
            • Drug substance synthetic route development
            • Drug substance process development
            • Form selection crystallization process development
            • Scale-up of drug substance
            • Preformulation
            • Preclinical formulation selection
            • First in Man Formulation/ Process Development
            • Analytical method development/validation
            • Release testing of drug substance and drug product
            • Work up Purification Steps
            • Telescoping & Process Refining
            • Initial Optimization
            • Formal stability of drug substance and drug product
          • Large Molecule
            • Cell Line development
            • Process Development
              • Upstream
                • Microbial
                • Mammalian
                • Others
              • Downstream
                • MABs
                • Recombinant proteins
                • Others
        • Contract Manufacturing
          • Small Molecule
            • Oral Solids
            • Liquid and Semi-solids
            • Injectables
            • Others
          • Large Molecule
            • MABs
            • Recombinant proteins
            • Others
      • North America IND CDMO Market, By End User
        • Clinical Pharmaceutical Companies
        • Biotech Companies
        • Others (Government, Research Institutes, Academic Institutes, etc.)
      • U.S.
        • U.S. IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • U.S. IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • U.S. IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • Canada
        • Canada IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • Canada IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • Canada IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
    • Europe
      • Europe IND CDMO Market, By Product
        • Small Molecule
        • Large Molecule
      • Europe IND CDMO Market, By Service
        • Contract Development
          • Small Molecule
            • Bioanalysis and DMPK studies
            • Toxicology Testing
            • Pathology and safety pharmacology studies
            • Drug substance synthetic route development
            • Drug substance process development
            • Form selection crystallization process development
            • Scale-up of drug substance
            • Preformulation
            • Preclinical formulation selection
            • First in Man Formulation/ Process Development
            • Analytical method development/validation
            • Release testing of drug substance and drug product
            • Work up Purification Steps
            • Telescoping & Process Refining
            • Initial Optimization
            • Formal stability of drug substance and drug product
          • Large Molecule
            • Cell Line development
            • Process Development
              • Upstream
                • Microbial
                • Mammalian
                • Others
              • Downstream
                • MABs
                • Recombinant proteins
                • Others
        • Contract Manufacturing
          • Small Molecule
            • Oral Solids
            • Liquid and Semi-solids
            • Injectables
            • Others
          • Large Molecule
            • MABs
            • Recombinant proteins
            • Others
      • Europe IND CDMO Market, By End User
        • Clinical Pharmaceutical Companies
        • Biotech Companies
        • Others (Government, Research Institutes, Academic Institutes, etc.)
      • U.K.
        • U.K. IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • U.K. IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • U.K. IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • Germany
        • Germany IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • Germany IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • Germany IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • France
        • France IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • France IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • France IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • Italy
        • Italy IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • Italy IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • Italy IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • Spain
        • Spain IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • Spain IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • Spain IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
    • Asia Pacific 
      • Asia Pacific  IND CDMO Market, By Product
        • Small Molecule
        • Large Molecule
      • Asia Pacific  IND CDMO Market, By Service
        • Contract Development
          • Small Molecule
            • Bioanalysis and DMPK studies
            • Toxicology Testing
            • Pathology and safety pharmacology studies
            • Drug substance synthetic route development
            • Drug substance process development
            • Form selection crystallization process development
            • Scale-up of drug substance
            • Preformulation
            • Preclinical formulation selection
            • First in Man Formulation/ Process Development
            • Analytical method development/validation
            • Release testing of drug substance and drug product
            • Work up Purification Steps
            • Telescoping & Process Refining
            • Initial Optimization
            • Formal stability of drug substance and drug product
          • Large Molecule
            • Cell Line development
            • Process Development
              • Upstream
                • Microbial
                • Mammalian
                • Others
              • Downstream
                • MABs
                • Recombinant proteins
                • Others
        • Contract Manufacturing
          • Small Molecule
            • Oral Solids
            • Liquid and Semi-solids
            • Injectables
            • Others
          • Large Molecule
            • MABs
            • Recombinant proteins
            • Others
      • Asia Pacific  IND CDMO Market, By End User
        • Clinical Pharmaceutical Companies
        • Biotech Companies
        • Others (Government, Research Institutes, Academic Institutes, etc.)
      • Japan
        • Japan IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • Japan IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • Japan IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • China
        • China IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • China IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • China IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • India
        • India IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • India IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • India IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • Australia
        • Australia IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • Australia IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • Australia IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • South Korea
        • South Korea IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • South Korea IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • South Korea IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
    • Latin America
      • Latin America IND CDMO Market, By Product
        • Small Molecule
        • Large Molecule
      • Latin America IND CDMO Market, By Service
        • Contract Development
          • Small Molecule
            • Bioanalysis and DMPK studies
            • Toxicology Testing
            • Pathology and safety pharmacology studies
            • Drug substance synthetic route development
            • Drug substance process development
            • Form selection crystallization process development
            • Scale-up of drug substance
            • Preformulation
            • Preclinical formulation selection
            • First in Man Formulation/ Process Development
            • Analytical method development/validation
            • Release testing of drug substance and drug product
            • Work up Purification Steps
            • Telescoping & Process Refining
            • Initial Optimization
            • Formal stability of drug substance and drug product
          • Large Molecule
            • Cell Line development
            • Process Development
              • Upstream
                • Microbial
                • Mammalian
                • Others
              • Downstream
                • MABs
                • Recombinant proteins
                • Others
        • Contract Manufacturing
          • Small Molecule
            • Oral Solids
            • Liquid and Semi-solids
            • Injectables
            • Others
          • Large Molecule
            • MABs
            • Recombinant proteins
            • Others
      • Latin America IND CDMO Market, By End User
        • Clinical Pharmaceutical Companies
        • Biotech Companies
        • Others (Government, Research Institutes, Academic Institutes, etc.)
      • Brazil 
        • Brazil IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • Brazil IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • Brazil  IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • Mexico
        • Mexico IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • Mexico IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • Mexico IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • Argentina
        • Argentina IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • Argentina IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • Argentina IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
    • Middle East & Africa 
      • Middle East & Africa  IND CDMO Market, By Product
        • Small Molecule
        • Large Molecule
      • Middle East & Africa  IND CDMO Market, By Service
        • Contract Development
          • Small Molecule
            • Bioanalysis and DMPK studies
            • Toxicology Testing
            • Pathology and safety pharmacology studies
            • Drug substance synthetic route development
            • Drug substance process development
            • Form selection crystallization process development
            • Scale-up of drug substance
            • Preformulation
            • Preclinical formulation selection
            • First in Man Formulation/ Process Development
            • Analytical method development/validation
            • Release testing of drug substance and drug product
            • Work up Purification Steps
            • Telescoping & Process Refining
            • Initial Optimization
            • Formal stability of drug substance and drug product
          • Large Molecule
            • Cell Line development
            • Process Development
              • Upstream
                • Microbial
                • Mammalian
                • Others
              • Downstream
                • MABs
                • Recombinant proteins
                • Others
        • Contract Manufacturing
          • Small Molecule
            • Oral Solids
            • Liquid and Semi-solids
            • Injectables
            • Others
          • Large Molecule
            • MABs
            • Recombinant proteins
            • Others
      • Middle East & Africa  IND CDMO Market, By End User
        • Clinical Pharmaceutical Companies
        • Biotech Companies
        • Others (Government, Research Institutes, Academic Institutes, etc.)
      • South Africa
        • South Africa IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • South Africa IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • South Africa IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • Saudi Arabia
        • Saudi Arabia IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • Saudi Arabia IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • Saudi Arabia IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)
      • UAE
        • UAE IND CDMO Market, By Product
          • Small Molecule
          • Large Molecule
        • UAE IND CDMO Market, By Service
          • Contract Development
            • Small Molecule
              • Bioanalysis and DMPK studies
              • Toxicology Testing
              • Pathology and safety pharmacology studies
              • Drug substance synthetic route development
              • Drug substance process development
              • Form selection crystallization process development
              • Scale-up of drug substance
              • Preformulation
              • Preclinical formulation selection
              • First in Man Formulation/ Process Development
              • Analytical method development/validation
              • Release testing of drug substance and drug product
              • Work up Purification Steps
              • Telescoping & Process Refining
              • Initial Optimization
              • Formal stability of drug substance and drug product
            • Large Molecule
              • Cell Line development
              • Process Development
                • Upstream
                  • Microbial
                  • Mammalian
                  • Others
                • Downstream
                  • MABs
                  • Recombinant proteins
                  • Others
          • Contract Manufacturing
            • Small Molecule
              • Oral Solids
              • Liquid and Semi-solids
              • Injectables
              • Others
            • Large Molecule
              • MABs
              • Recombinant proteins
              • Others
        • UAE IND CDMO Market, By End User
          • Clinical Pharmaceutical Companies
          • Biotech Companies
          • Others (Government, Research Institutes, Academic Institutes, etc.)

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2016 to 2028
  • Market estimates and forecast for product segments up to 2028
  • Regional market size and forecast for product segments up to 2028
  • Market estimates and forecast for application segments up to 2028
  • Regional market size and forecast for application segments up to 2028
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.